Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial.

Saved in:
Bibliographic Details
Title: Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial.
Authors: Adams AM; Department of Surgery, Brooke Army Medical Center, San Antonio, TX, USA., Carpenter EL; Department of Surgery, Brooke Army Medical Center, San Antonio, TX, USA. elcarp@mac.com., Clifton GT; Department of Surgery, Brooke Army Medical Center, San Antonio, TX, USA., Vreeland TJ; Department of Surgery, Brooke Army Medical Center, San Antonio, TX, USA., Chick RC; Department of Surgery, Brooke Army Medical Center, San Antonio, TX, USA., O'Shea AE; Department of Surgery, Brooke Army Medical Center, San Antonio, TX, USA., McCarthy PM; Department of Surgery, Brooke Army Medical Center, San Antonio, TX, USA., Kemp Bohan PM; Department of Surgery, Brooke Army Medical Center, San Antonio, TX, USA., Hickerson AT; Department of Surgery, Brooke Army Medical Center, San Antonio, TX, USA., Valdera FA; Department of Surgery, Brooke Army Medical Center, San Antonio, TX, USA., Tiwari A; Department of Surgery, University of Texas Health Sciences Center, San Antonio, Texas, USA., Hale DF; Department of Surgery, Brooke Army Medical Center, San Antonio, TX, USA., Hyngstrom JR; Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Berger AC; Department of Surgery, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Jakub JW; Department of Surgery, Mayo Clinic, Jacksonville, FL, USA., Sussman JJ; Department of Surgery, University of Cincinnati, Cincinnati, OH, USA., Shaheen MF; Department of Medicine, University of Arizona, Tucson, AZ, USA., Yu X; Department of Biological Sciences, Clemson University, Clemson, SC, USA., Wagner TE; Orbis Health Solutions, Greenville, SC, USA., Faries MB; Department of Surgery, The Angeles Clinic, Santa Monica, CA, USA., Peoples GE; Cancer Vaccine Development Program, San Antonio, TX, USA.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Mar; Vol. 72 (3), pp. 697-705. Date of Electronic Publication: 2022 Sep 01.
Publication Type: Randomized Controlled Trial; Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0851
DOI:10.1007/s00262-022-03272-8